v3.26.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Stockholders’ Equity

 

Common Stock

 

   March 31,   December 31, 
Description  2026   2025 
Authorized shares   13,969,410    13,969,410 
Issued and outstanding   6,084,208    5,426,400 
Par value per share   0.001    0.001 

 

Preferred Stock

 

   March 31,   December 31, 
Series Seed 1  2026   2025 
Authorized shares   516,298    516,298 
Issued and outstanding   516,298    516,298 
Par value per share   0.001    0.001 

 

   March 31,   December 31, 
Series Seed 2  2026   2025 
Authorized shares   115,038    115,038 
Issued and outstanding   115,038    115,038 
Par value per share   0.001    0.001 

 

   March 31,   December 31, 
Series A  2026   2025 
Authorized shares   687,500    687,500 
Issued and outstanding   611,299    611,299 
Par value per share   0.001    0.001 
Summary of Warrant Activity

The following table summarizes warrant activity for the three months ended March 31, 2026:

 

   Number of   Weighted-
Average
 
   Shares   Exercise Price 
Outstanding at December 31, 2025   893,393   $0.003 
Issued   -    - 
Exercised   -    - 
Expired   -    - 
Outstanding at March 31, 2026   893,393   $0.003 
Schedule Of Valuation Performed Using Assumptions

The valuation of the Series A Warrants required the use of significant assumptions, including expected volatility, risk-free interest rate, and the probability of achieving the market-based vesting condition.

 

Key assumptions used in the valuation included:

 

Option pricing model expected term: 1.5 years

 

Warrant expected term: 10.0 years

 

Volatility: 70%

 

Risk-free interest rate: 4.23%

 

Dividend yield: 0%

 

Simulation inputs: 100,000 paths with monthly time steps